Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Capital Expenditures (2024 - 2025)

BioAge Labs (BIOA) has disclosed Capital Expenditures for 2 consecutive years, with $112000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 330.77% to $112000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $719000.0 through Dec 2025, up 96.45% year-over-year, with the annual reading at $719000.0 for FY2025, 96.45% up from the prior year.
  • Capital Expenditures hit $112000.0 in Q4 2025 for BioAge Labs, up from $22000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $426000.0 in Q1 2025 to a low of $22000.0 in Q3 2025.